Related references
Note: Only part of the references are listed.
Article
Biochemistry & Molecular Biology
Shuo Feng et al.
Summary: Defined levels of SARS-CoV-2-specific binding and neutralizing antibodies elicited by the COVID-19 vaccine were identified as correlates of protection against symptomatic infection. Higher levels of immune markers were correlated with a reduced risk of symptomatic infection. The data can be used to extrapolate efficacy estimates to new populations.
Letter
Medicine, General & Internal
Saman Saadat et al.
Summary: This study compared the titers of binding and neutralizing antibodies in healthcare workers previously infected with SARS-CoV-2 after receiving a single dose of mRNA coronavirus vaccine.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Editorial Material
Medicine, General & Internal
Sonja A. Rasmussen et al.
Summary: This review summarizes the epidemiology of SARS-CoV-2 infection in pregnant and lactating women, its effects on perinatal outcomes, and compiles guidance on the safety of coronavirus vaccines during pregnancy and while breastfeeding from the CDC, FDA, and obstetrics-gynecology specialty organizations.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Article
Public, Environmental & Occupational Health
Nina M. Molenaar et al.
Summary: This study aimed to investigate the effects of SARS-CoV-2 infection during pregnancy on pregnancy outcomes using serological tests. The results showed that seropositivity for SARS-CoV-2 during pregnancy was not associated with adverse maternal or neonatal outcomes in a cohort sample from New York City.
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
(2021)
Article
Cell Biology
Caroline Atyeo et al.
Summary: During pregnancy, significant immunological changes occur to make the mother immunologically tolerant to the fetus and continue to protect the dyad against pathogens during and after birth. Pregnant women may be less responsive to vaccination or exhibit altered immune responses to vaccination, highlighting the importance of following prime-boost timelines to ensure full immunity is attained in this vulnerable population.
SCIENCE TRANSLATIONAL MEDICINE
(2021)
Article
Obstetrics & Gynecology
Kathryn J. Gray et al.
Summary: The study found that pregnant and lactating women had equivalent antibody titers after receiving the coronavirus disease 2019 mRNA vaccine compared to nonpregnant women, and these titers were higher than those induced by natural infection. Vaccine-induced antibodies were present in umbilical cord blood and breastmilk samples, transferring immunity to neonates through placenta and breastmilk.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
(2021)
Article
Immunology
David Forgacs et al.
Summary: In this study, a serological assay was used to measure antibody responses post-vaccination and compared to immune responses from natural infection. The results showed that vaccination induced a more robust immune reaction and that levels of neutralizing and anti-RBD antibody binding were significantly higher in pre-immune participants compared to immunologically naive participants.
FRONTIERS IN IMMUNOLOGY
(2021)
Editorial Material
Medicine, General & Internal
Stephen J. Kent et al.
Article
Multidisciplinary Sciences
Zijun Wang et al.
Summary: Despite challenges posed by COVID-19 variants, convalescent individuals receiving mRNA vaccines exhibit robust and long-lasting immune responses against circulating SARS-CoV-2 variants, providing hope for effective control of the pandemic.
Article
Biochemistry & Molecular Biology
Fatima Amanat et al.
